Nuclear medicine vendor Digirad of San Diego has launched its initial public offering, with 5.5 million shares of common stock going on sale at a price of $12 per share.
The company said the offering's net proceeds were approximately $59.7 million. In addition, the firm has granted its underwriters a 30-day option to purchase an additional 825,000 shares of common stock at the IPO price to cover over-allotments, if any.
The shares are listed on the NASDAQ National Market under the symbol DRAD.
By AuntMinnie.com staff writersJune 10, 2004
Related Reading
Digirad puts IPO plans back on track, March 19, 2004
Digirad launches new OptiCount collimator, February 11, 2004
Digirad subsidiary gets ICANL accreditation, February 2, 2004
Digirad signs Johns Hopkins, December 10, 2003
Digirad achieves profitability, October 22, 2003
Copyright © 2004 AuntMinnie.com